← Back to patent-cliff list
富马酸福莫特罗
Tier C — Watch / tradeFormoterol Fumarate
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRB2
Brand：Eolus、Atimos、Oxeze、Oxis、奥克斯都保、Broncoral、Foradil Aerolizer、Foradil、Foradil Certihaler、Oxis Turbuhaler、Atock、Perforomist
Indications (approved)：慢性阻塞性肺疾病、气肿、哮喘、支气管炎
Regional status
US
临床二期
2002-07-01
EU
批准上市
1996-10-14
China
批准上市
2000-02-03
Japan
批准上市
2012-06-29
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Formoterol Fumarate?
Approved indications include: 慢性阻塞性肺疾病, 气肿, 哮喘, 支气管炎.
When does the Formoterol Fumarate patent expire?
No public expiry year is available for Formoterol Fumarate yet; this page updates once verified.
How do I get a quote for Formoterol Fumarate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25